City of Hope – Karen Aboody
Development of Next Generation of Neural Progenitor Cells
Fred Hutchinson Cancer Research Center — Patrick Paddison
Examining the multiple active pathways of glioblastoma multiforme (GBM)
Jackson Laboratory/Swedish Medical Center
Development of Orthotopic Xenograft GBM Pre-Clinical Mouse Models
Johns Hopkins — Greg Riggins
Phase II Clinical Trial of Mebendazole
MD Anderson/Baylor College of Medicine — Xiaonan Li
Role of Nerium Oleander extract and oleandrin on glioblastoma
Swedish Medical Center — Greg Foltz
Phase 1 Study of the Metabolism and Distribution of a Subpharmacologic Dose of Lightly-labeled 14C-Temozolomide in Newly Diagnosed Glioblastoma Patients
UCSF/Pfizer – Mike Prados
Co-Development of a novel Cdk4/6 Inhibitor to treat GBM
University of Florida — Brent Reynolds
Bone Morphogenic Protein (BMP) as a novel differentiating agent in the treatment of Glioblastoma
University of West Florida — Raid Amin
An Epidemiological Surveillance of Brain Cancer in Florida
University of Florida — Erin Dunbar
Circulating Tumor Cells (CTCs) in Patients with Glioblastoma Multiforme (GBM)
University of Central Florida – Sic Chan
Targeting the brain-specific mitochondrial uncoupling protein inhibits metabolic flexibility and survival of glioblastoma multiforme
